An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Biote Announces Participation in the Jefferies Healthcare Conference 2022
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Biote Corp. (Nasdaq: BTMD) announces a presentation by CEO Terry Weber at the Jefferies 2022 Healthcare Conference on June 8, 2022, at 1:30 p.m. ET, in New York City. The event will be webcasted live with a replay available for 90 days. In addition, Weber and Chairman Marc Beer will engage in investor meetings during the conference. Biote focuses on hormone optimization, training practitioners to detect and address hormone-related aging conditions. The company went public on Nasdaq on May 27, 2022.
Positive
Scheduled presentation at a prominent healthcare conference, enhancing visibility.
Participation of CEO and Chairman in investor meetings, indicating active investor engagement.
Company focuses on a niche with potential growth in hormone optimization market.
Negative
None.
IRVING, Texas--(BUSINESS WIRE)--
biote Corp. (“Biote” or the “Company”) (Nasdaq: BTMD), a high growth, differentiated medical practice-building business within the hormone optimization space, today announces that Terry Weber, Biote’s Chief Executive Officer, is scheduled to present at the Jefferies 2022 Healthcare Conference in New York City on Wednesday, June 8, 2022 at 1:30 p.m. Eastern Time. A live webcast of the presentation will be available here. A replay of the available webcast will be accessible for 90 days following the live event.
Terry Weber and Marc Beer, Biote’s Chairman, will also be participating in investor meetings throughout the conference.
About Biote
Biote is a woman-led company operating a high growth, differentiated medical practice-building business within the hormone optimization space. Biote trains practitioners how to identify and treat early indicators of hormone-related aging conditions. Biote went public on Nasdaq on May 27, 2022. To learn more about Biote, please visit www.biote.com.
